Nasilin, Baby Boy .

HRN: 28-52-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2026
AMPICILLIN 250MG (VIAL)
02/06/2026
02/13/2026
IVTT
145mg
Q12h
PSNB
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: